GNCA News and Press, Genocea Biosciences Inc. From 04/23/20

CAMBRIDGE, Mass., April 23, 2020 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc . (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, will host its first quarter 2020 financial results and corporate update conference call and live audio webcast ...

Introduction Genocea Biosciences ( GNCA ) is a clinical-stage biotech company working on developing novel cancer immunotherapies. With its proprietary discovery platform, ATLAS, the company can identify immunotherapy targets based on an individual's tumor antigen-specific T cell responses ...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

CAMBRIDGE, Mass., April 08, 2020 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc.  (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that Chip Clark, president and chief executive officer, will present a corporate overview ...

CAMBRIDGE, Mass., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc . (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that Chip Clark, president and chief executive officer, will present a corporate overview at the...

Coronavirus Isn’t The Only Thing Driving Penny Stocks In a statement made on February 25, economist Mohamed El-Erian said to “resist automatically buying the dip after coronavirus-inspired stock-market sell-offs.” While broader markets jumped early on Tuesday morning, over...

CAMBRIDGE, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc . (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that Chip Clark, president and chief executive officer, will present a corporate overview at the...

Genocea Biosciences, Inc. (GNCA) Q4 2019 Earnings Conference Call February 13, 2020, 08:30 AM ET Company Participants Dan Ferry - Managing Director, LifeSci Advisors Chip Clark - President and CEO Diantha Duvall - CFO Tom Davis - Chief Medical Officer Jessica Flechtner - Chie...

Genocea Biosciences (NASDAQ: GNCA ): Q4 GAAP EPS of -$0.34 beats by $0.05 . More news on: Genocea Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

ATLAS TM identifies Inhibigens tm that can undermine immunotherapy Dosed first patient in Part B of GEN-009 neoantigen vaccine Phase 1/2a trial Progressed GEN-011 neoantigen cell therapy - IND filing expected in Q2 2020 Appointed Dr. Gisela Schwab to Genocea’s Board o...